Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Rheumatoid arthritis (RA) affects about 1% of the world's population and can lead to loss of joint function, reduced mobility, and permanent damage to cartilage and bone. Treatment options for RA primarily include disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, but the development of new drugs has complicated treatment decisions. Weighing treatment options for patients with RA largely depends on three major factors: efficacy, adverse reaction profile, and cost. A review of the literature supports methotrexate monotherapy as the current best-practice model for treating RA, compared with combination therapy of methotrexate and/or other DMARDs. Copyright © 2023 American Academy of Physician Associates.

Citation

Ihor Korol, Robin H Baumeister. Treating rheumatoid arthritis. JAAPA : official journal of the American Academy of Physician Assistants. 2023 Sep 01;36(9):1-5

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 37668490

View Full Text